Most Popular
-
6
[Graphic News] More Koreans say they plan long-distance trips this year
![[Graphic News] More Koreans say they plan long-distance trips this year](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/17/20240417050828_0.gif&u=)
-
7
[KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs
![[KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/18/20240418050645_0.jpg&u=20240419100350)
-
8
North Korea removes streetlights along cross-border roads with South
-
9
Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official
-
10
Farming households dip below 1m for first time in 2023
![[Graphic News] More Koreans say they plan long-distance trips this year](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/17/20240417050828_0.gif&u=)
![[KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/18/20240418050645_0.jpg&u=20240419100350)
Celltrion, a local bio company, on Monday had its biosimilar for an antibody against arthritis approved.
This is the first time an antibody copy treatment was approved in the world, the company said.
The Korea Food and Drug Administration on Monday authorized “Remsima,” a biosimilar of Janssen’s “Remicade.” The company has conducted clinical trials on a total of 856 patients from 29 countries.
The drug maker said Remsima could replace Remicade for use for rheumatic arthritis, ankylosing spondylitis, psoriasis and other conditions.
This is the first time an antibody copy treatment was approved in the world, the company said.
The Korea Food and Drug Administration on Monday authorized “Remsima,” a biosimilar of Janssen’s “Remicade.” The company has conducted clinical trials on a total of 856 patients from 29 countries.
The drug maker said Remsima could replace Remicade for use for rheumatic arthritis, ankylosing spondylitis, psoriasis and other conditions.
-
Articles by Korea Herald
![[From the Scene] Monks, Buddhists hail return of remains of Buddhas](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/04/19/20240419050617_0.jpg&u=20240419175937)
![[KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/04/18/20240418050645_0.jpg&u=20240419100350)
![[Today’s K-pop] Illit drops debut single remix](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/04/19/20240419050612_0.jpg&u=)